Losartan Impurity 12 | CAS 2353190-33-5 - Request Quote
Losartan Impurity 12
| SZ CAT No: | SZ-L028046 |
| CAS No | 2353190-33-5 |
| Mol.F. | C8H12ClN5 |
| Mol.Wt. | 213.7 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Losartan Impurity 12 is chemically 5-(Azidomethyl)-2-butyl-4-chloro-1H-imidazole. Losartan Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Losartan Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Losartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2353190-33-5
Purchase 2353190-33-5
Order 2353190-33-5
Enquire 2353190-33-5
price of 2353190-33-5
2353190-33-5 Supplier
2353190-33-5 Manufacturer
2353190-33-5 Exporter
buy high quality Losartan Impurity 12
Purchase Losartan Impurity 12
Losartan Impurity 12 suppliers
Losartan Impurity 12 manufacturers
Losartan Impurity 12 price
Order Losartan Impurity 12
Enquire Losartan Impurity 12
Losartan Impurity 12 cost
Losartan Impurity 12 Supplier
Losartan Impurity 12 Distributor
Losartan Impurity 12 for Method Validation
Losartan Reference Standard
Losartan Impurity 12 for ANDA Filing
Losartan Impurity 12 for Forced Degradation Studies
Losartan Impurity 12 Identification Standards
Losartan Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.